Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Maarten J Postma. (2012) Dynamic modeling for pandemic influenza. Expert Review of Vaccines 11:5, pages 543-546.
Read now
Read now
Maarten J Postma, George Milne, E Anthony S Nelson, Bruce Pyenson, Marcello Basili, Richard Coker, John Oxford & Louis P Garrison. (2010) Pharmaceutical interventions for mitigating an influenza pandemic: modeling the risks and health-economic impacts. Expert Review of Anti-infective Therapy 8:12, pages 1431-1439.
Read now
Read now
Articles from other publishers (21)
Constantine Vardavas, Katerina Nikitara, Satomi Odani & Emmanouil Symvoulakis. (2022) The predictors and association between knowledge of vaccines and vaccination among adults and children in 28 European Countries, 2019. Population Medicine 4:March, pages 1-8.
Crossref
Crossref
Kang-Hua Cao, Paul Damien, Chi-Keung Woo & Jay Zarnikau. (2021) A Bayes Decision Rule to Assist Policymakers during a Pandemic. Healthcare 9:8, pages 1023.
Crossref
Crossref
Przemysław Borkowski, Magdalena Jażdżewska-Gutta & Agnieszka Szmelter-Jarosz. (2021) Lockdowned: Everyday mobility changes in response to COVID-19. Journal of Transport Geography 90, pages 102906.
Crossref
Crossref
Edwin Calilung, Jason Espanola, Elmer Dadios, Alvin Culaba, Edwin Sybingco, Argel Bandala, Ryan Rhay Vicerra, Alma Bella Madrazo, Laurence Gan Lim, Robert Kerwin Billones, Siegfred Lopez, Dino Dominic Ligutan, Julius Palingcod & Carl John Patrick Castillo. (2020) Design and Development of an Automated Compression Mechanism for a Bag-Valve-Mask-Based Emergency Ventilator. Design and Development of an Automated Compression Mechanism for a Bag-Valve-Mask-Based Emergency Ventilator.
C. Neuwirth, C. Gruber & T. Murphy. (2020) Investigating duration and intensity of Covid-19 social-distancing strategies. Scientific Reports 10:1.
Crossref
Crossref
Steven E. Salterio. (2020) Accounting for the unaccountable – coping with COVID. Journal of Accounting & Organizational Change 16:4, pages 557-578.
Crossref
Crossref
Ann van Ackere & Peter J. Schulz. (2020) Explaining vaccination decisions: A system dynamics model of the interaction between epidemiological and behavioural factors. Socio-Economic Planning Sciences 71, pages 100750.
Crossref
Crossref
Mélanie Drolet, Élodie Bénard, Mark Jit, Raymond Hutubessy & Marc Brisson. (2018) Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature. Value in Health 21:10, pages 1250-1258.
Crossref
Crossref
D. B. C. Wu, N. Chaiyakunapruk, C. Pratoomsoot, K. K. C. Lee, H. Y. Chong, R. E. Nelson, P. F. Smith, C.M. Kirkpatrick, M. A. Kamal, K. Nieforth, G. Dall, S. Toovey, D. C. M. Kong, A. Kamauu & C. R. Rayner. (2018) Cost-utility analysis of antiviral use under pandemic influenza using a novel approach – linking pharmacology, epidemiology and heath economics. Epidemiology and Infection 146:4, pages 496-507.
Crossref
Crossref
Nita Madhav, Ben Oppenheim, Mark Gallivan, Prime Mulembakani, Edward Rubin & Nathan Wolfe. 2017. Disease Control Priorities, Third Edition (Volume 9): Improving Health and Reducing Poverty. Disease Control Priorities, Third Edition (Volume 9): Improving Health and Reducing Poverty
315
345
.
Hélène Pasquini-Descomps, Nathalie Brender & David Maradan. (2017) Value for Money in H1N1 Influenza: A Systematic Review of the Cost-Effectiveness of Pandemic Interventions. Value in Health 20:6, pages 819-827.
Crossref
Crossref
Andreas Handel & Mark H Ebell. (2015) Neuraminidase inhibitors for influenza: fully evaluating benefits and harms. The Lancet Respiratory Medicine 3:3, pages e7-e8.
Crossref
Crossref
Tom Drake, Zaid Chalabi & Richard Coker. (2015) Buy now, saved later? The critical impact of time-to-pandemic uncertainty on pandemic cost-effectiveness analyses. Health Policy and Planning 30:1, pages 100-110.
Crossref
Crossref
Tamara V. Feldblyum & David M. Segal. 2015. Global Virology I - Identifying and Investigating Viral Diseases. Global Virology I - Identifying and Investigating Viral Diseases
761
789
.
Hamed Yarmand, Julie S Ivy & Stephen D Roberts. (2013) Identifying optimal mitigation strategies for responding to a mild influenza epidemic. SIMULATION 89:11, pages 1400-1415.
Crossref
Crossref
Shang Xia, Jiming Liu & William Cheung. (2013) Identifying the Relative Priorities of Subpopulations for Containing Infectious Disease Spread. PLoS ONE 8:6, pages e65271.
Crossref
Crossref
Tom L DrakeZaid ChalabiRichard Coker. (2012) Cost–effectiveness analysis of pandemic influenza preparedness: what’s missing?. Bulletin of the World Health Organization 90:12, pages 940-941.
Crossref
Crossref
Román Pérez Velasco, Naiyana Praditsitthikorn, Kamonthip Wichmann, Adun Mohara, Surachai Kotirum, Sripen Tantivess, Constanza Vallenas, Hande Harmanci & Yot Teerawattananon. (2012) Systematic Review of Economic Evaluations of Preparedness Strategies and Interventions against Influenza Pandemics. PLoS ONE 7:2, pages e30333.
Crossref
Crossref
James R. Smith, Craig R. Rayner, Barbara Donner, Martina Wollenhaupt, Klaus Klumpp & Regina Dutkowski. (2011) Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience. Advances in Therapy 28:11, pages 927-959.
Crossref
Crossref
T. Déirdre Hollingsworth, Don Klinkenberg, Hans Heesterbeek & Roy M. Anderson. (2011) Mitigation Strategies for Pandemic Influenza A: Balancing Conflicting Policy Objectives. PLoS Computational Biology 7:2, pages e1001076.
Crossref
Crossref
Marcelo de Araujo. (2021) The Nascent Field of Pandemic Ethics: Prevention, Mitigation, Responsibility, and Adaptation. SSRN Electronic Journal.
Crossref
Crossref